IHS Chemical Week

People & Business :: M&A

Lonza Completes Arch Deal; Lists on Singapore Stock Exchange

6:44 AM MDT | October 20, 2011 | Kerri Walsh

Lonza has completed its acquisition of Arch Chemicals for $1.4 billion, or $47.20/share. Lonza says it owns more than 90% of Arch’s outstanding shares, and expects to complete the deal through a short-form merger no later than October 21. Upon completion of the merger, Arch will become an indirect, wholly-owned subsidiary of Lonza.   The acquisition creates the largest biocides business, and expands Lonza’s non-pharma life science business, says Lonza CEO Stefan Borgas. “After having built the world's leading pharmaceutical contract...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Not an IHS Chemical Week member yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine in print or digital format
  • Critical daily news and analysis on chemweek.com
  • Free mobile edition 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now

100% Satisfaction Guarantee
If at any time you are not completely satisfied with IHS Chemical Week, simply notify us and we'll refund the balance of your paid subscription - no problem.

Learn more about group subscriptions and site licenses.


contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa